Literature DB >> 10506449

Massive myocardial necrosis in thrombotic thrombocytopenic purpura: a case report and review of the literature.

S H Podolsky1, A Zembowicz, F J Schoen, R J Benjamin, L A Sonna.   

Abstract

Thrombotic thrombocytopenic purpura (TTP) is an uncommon syndrome resulting from diffuse occlusion of small arterioles and capillaries by hyaline microthrombi. It is characterized by fever, thrombocytopenic purpura, microangiopathic hemolytic anemia, and neurologic and renal dysfunction. While cardiac pathology in TTP is commonly seen at autopsy, clinical cardiac dysfunction is rare and typically results from conduction system involvement. While 3% to 8% of patients with TTP report chest pain on admission, reports of fatal ventricular pump failure are extremely rare. We now report a case of TTP resulting in death from widespread myocardial necrosis. This patient presented with elevated cardiac enzymes and electrocardiographic disturbances that mimicked viral myocarditis, as well as a profound thrombocytopenia. Such a case may represent the extreme of a distribution of cardiac involvement in TTP or the consequence of an unidentified autoimmune process capable of precipitating severe myocardial TTP.

Entities:  

Mesh:

Year:  1999        PMID: 10506449     DOI: 10.5858/1999-123-0937-MMNITT

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  ST-segment elevation myocardial infarction treated with thrombolytic therapy in a patient with thrombotic thrombocytopenic purpura.

Authors:  Jacob A Doll; Jacob P Kelly
Journal:  J Thromb Thrombolysis       Date:  2014-07       Impact factor: 2.300

Review 2.  Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis.

Authors:  Nay M Tun; Gina M Villani
Journal:  J Thromb Thrombolysis       Date:  2012-10       Impact factor: 2.300

3.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 4.  Thrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiency.

Authors:  Han-Mou Tsai
Journal:  Hematol Oncol Clin North Am       Date:  2007-08       Impact factor: 3.722

5.  Dilated cardiomyopathy during the course of hemolytic uremic syndrome.

Authors:  Alexandra Alexopoulou; Spyros P Dourakis; Christos Zovoilis; Emmanouel Agapitos; Aris Androulakis; Anna Filiotou; Athanasios J Archimandritis
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

6.  Severe left ventricular systolic dysfunction in a patient with a typical haemolytic-uraemic syndrome treated with rituximab-coincidence or cause?

Authors:  Colin J Petrie; Robin A P Weir; Mitchell M Lindsay; Neal Padmanabhan; Kenny Douglas
Journal:  NDT Plus       Date:  2010-04-09

Review 7.  Ticagrelor-induced thrombotic thrombocytopenic purpura: A case report and review of the literature.

Authors:  Xiaoya Wang; Shufang Zhang; Leiqing Li; Junjie Hua; Lei Zhu; Libin Li; Gensheng Zhang
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Thrombotic thrombocytopenic purpura presenting as acute coronary syndrome.

Authors:  Jason Aboudi Mouabbi; Rami Zein; Zyad Kafri; Ayad Al-Katib; Tarik Hadid
Journal:  Clin Case Rep       Date:  2016-06-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.